ClinicalTrials.gg
Drug

Pioglitazone clinical trials

Also written Actos, AD4833 and BR3006B.

studies test it
336
open now
29
in phase 3
52
first study started
2000

How each study uses Pioglitazone is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Pioglitazone studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
15 Jul 1999 · ACTOS · NDA 021073 (FDA, Drugs@FDA)
European Union
11 Oct 2000 · Glustin · EMEA/H/C/000286 (EMA; now withdrawn)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Pioglitazone
222
Pioglitazone hydrochloride
13
Pioglitazone 30 mg
10
Pioglitazone 15mg
9
Pioglitazone 45 mg
8

Brand

Actos
136
zactos
1

Development codes

AD4833
15
BR3006B
2
BR3003A-1
1
BR3003B-1
1
TAK-379
1

In one entry with another drug

Given together, or one or the other

Pioglitazone and Metformin
7
Pioglitazone and azilsartan
2
Pioglitazone and insulin
2
Pioglitazone and Glimepiride
2

Studies by the year they started

333 studies that test it; most in 2008 (34)

Studies that test Pioglitazone, by start year
YearStudies
20004
20013
20028
200316
200412
200523
200619
200723
200834
200927
201017
201116
201211
201311
20148
20158
201614
20176
201812
20197
20209
20217
20229
20238
20247
20259
20265

Who runs them

Industry 72 · Other 264

Takeda (33) · The University of Texas Health Science Center at San Antonio (13) · University of Texas Southwestern Medical Center (7) · Stanford University (6) · The University of Texas Health Science Center, Houston (5) · AstraZeneca (5) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (5) · Tehran University of Medical Sciences (5)

Often tested with

Tested in the same studies.

Metformin (43) · Sitagliptin (12) · Empagliflozin (10) · Dapagliflozin (9) · Alogliptin (6) · Atorvastatin (4) · Glimepiride (4) · Canagliflozin (3)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 14, 1 in phase 3

Studies that test Pioglitazone, phase 3 first.

Studies

Open first, then newest update. How each study uses Pioglitazone is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 336

See all 336 studies that test Pioglitazone →

Given beside what is tested · 39 — Pioglitazone is usual care or a partner of the new treatment

Showing 20 of 39.

As the comparator · 43 — what is tested is compared with Pioglitazone

Showing 20 of 43.

Codes

What other systems call Pioglitazone · ClinicalTrials.gg INT006661

  • MeSH (NLM) D000077205PioglitazoneConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) X4OV71U42SPIOGLITAZONEConfirmed FDA, NLM, Wikidata
  • RxNorm 33738Confirmed FDA, Wikidata
  • Wikidata Q417765(RS)-pioglitazoneConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C71633PioglitazoneOne source FDA
  • DrugBank DB01132One source Wikidata

Also registered as pioglitazone hydrochloride (UNII JQT35NPK6C · RxNorm 259319).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.